Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022.
Background and aims: Extended release buprenorphine injection (INJ‐BUP) has been available in the United States since 2018. INJ‐BUP has the potential to positively impact opioid use disorder (OUD) treatment outcomes by providing additional treatment options. As one of the largest payers of OUD treat...
| Publicado en: | Addiction Vol. 119; no. 12; pp. 2211 - 2216 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Dec2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |